** Shares of Indian pharma and life sciences company
Jubilant Pharmova JUBA.NS fall as much as 10.49% to 311.60
rupees, lowest level in over four months
** Co reports net loss of 156.7 mln in third quarter; core
profit falls about 25% to 1.46 bln rupees from the previous year
** Lower COVID-19 related deals in sterile injectables
business, adverse impact on the radiopharmaceuticals business
due to generated supply outage and lower volumes in drug
discovery services business hurt the profitability, company says
** About 353,908 shares change hands as of 2:02 p.m. IST,
nearly quadruple the 30-day avg of 98,758 shares
** Of the four analysts tracking the company, two maintain
"buy" and two suggest "hold"; median TP is 406.60 rupees -
Refinitiv data
($1 = 82.1300 Indian rupees)
(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; Mobile:
+919769003463))